- SUPN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $42.2 million.
- SUPN has traded 220,039 shares today.
- SUPN is down 3% today.
- SUPN was up 6.7% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in SUPN with the Ticky from Trade-Ideas. See the FREE profile for SUPN NOW at Trade-Ideas More details on SUPN: Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. SUPN has a PE ratio of 22. Currently there are 5 analysts that rate Supernus Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Supernus Pharmaceuticals has been 1.0 million shares per day over the past 30 days. Supernus has a market cap of $764.7 million and is part of the health care sector and drugs industry. The stock has a beta of 0.81 and a short float of 6.4% with 0.86 days to cover. Shares are up 92.9% year-to-date as of the close of trading on Thursday.